Drug repositioning: Using psychotropic drugs for the treatment of glioma-Reference-Cited by-同舟云学术

Drug repositioning: Using psychotropic drugs for the treatment of glioma

Published:2022-02 Issue: Volume:527 Page:140-149
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

You Fangting,Zhang Caiyi,Liu Xiaoxiao,Ji Daofei,Zhang Tong,Yu Rutong,Gao Shangfeng

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference100 articles.

1. Trends and patterns of incidence of diffuse glioma in adults in the United States, 1973-2014;Li;Cancer Med-Us,2018

2. OSgbm: an online consensus survival analysis web server for glioblastoma;Dong;Front. Genet.,2019

3. Progression-free but No overall survival benefit for adult patients with bevacizumab therapy for the treatment of newly diagnosed glioblastoma: a systematic review and meta-analysis;Kaka;Cancers,2019

4. Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance;Tomar;Biochim. Biophys. Acta Rev. Canc,2021

5. Treatment of glioblastoma in older adults;Braun;Curr. Oncol. Rep.,2017

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond Psychotropic: Potential Repurposing of Fluoxetine toward Cancer Therapy;International Journal of Molecular Sciences;2024-06-07

2. Overcoming Barriers in Glioblastoma—Advances in Drug Delivery Strategies;Cells;2024-06-07

3. Polo-like kinase 4 promotes tumorigenesis and glucose metabolism in glioma by activating AKT1 signaling;Cancer Letters;2024-03

4. Antidepressants and survival in glioma: Unraveling a complex puzzle;Neuro-Oncology Practice;2024-02-02

5. Chronic stress as an emerging risk factor for the development and progression of glioma;Chinese Medical Journal;2024-01-18